CRESCENZO PISANO: Open Payments
NPI 1144336769 · SAN PEDRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,318 in 21 payments from 11 companies in 2025. Trend: 2023 $2,588 · 2024 $2,780 · 2025 $2,318
Food & beverage: $2,318
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $622 |
| Novo Nordisk Inc | 6 | $495 |
| Abbott Laboratories | 1 | $165 |
| Teleflex LLC | 1 | $155 |
| Boston Scientific Corporation | 1 | $148 |
| Amgen Inc. | 1 | $126 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| Lilly USA, LLC | 1 | $124 |
| Kowa Pharmaceuticals America, Inc. | 1 | $118 |
Products named: Wegovy, AIRSUPRA, BREZTRI, FREESTYLE LIBRE 3, UROLIFT, FARAPULSE, CAPLYTA, VRAYLAR.
Industry payments across CA — which companies pay providers there.
